Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-02 Sale | 2024-02-05 8:50 pm | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit Director | 63,795 | $1.37 | $87,399 | 744,997 (Direct) | View |
| 2023-08-28 Sale | 2023-08-30 4:21 pm | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit Director | 9,040 | $1.26 | $11,390 | 788,792 (Direct) | View |
| 2023-02-03 Sale | 2023-02-06 4:15 pm | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO and President | 12,286 | $1.81 | $22,238 | 797,832 (Direct) | View |
| 2021-12-27 Sale | 2021-12-29 6:26 pm | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO and President | 8,000 | $14.58 | $116,666 | 630,845 (Direct) | View |
| 2020-11-03 Sale | 2020-11-05 7:00 pm | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO and President | 9,507 | $14.39 | $136,825 | 1,062,805 (Direct) | View |
| 2020-10-23 Sale | 2020-10-27 5:32 pm | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO and President | 20 | $14.25 | $285 | 570,133 (Direct) | View |
| 2020-10-13 Sale | 2020-10-15 8:24 pm | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO and President | 14,472 | $14.28 | $206,709 | 1,074,594 (Direct) | View |
| 2020-09-08 Sale | 2020-09-10 9:51 pm | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO and President | 774 | $14.25 | $11,030 | 584,625 (Direct) | View |
| 2020-07-07 Sale | 2020-07-09 6:48 pm | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO and President | 3,047 | $14.29 | $43,552 | 1,107,274 (Direct) | View |
| 2020-06-22 Sale | 2020-06-29 9:21 pm | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO and President | 17,180 | $14.3 | $245,699 | 2,180,064 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-10-05 Option Award | 2023-10-10 5:18 pm | N/A N/A | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit Director | 20,000 | $0 | 808,792 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 7:38 pm | N/A N/A | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO and President | 531,914 | $0 | 810,118 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 4:18 pm | N/A 2032-02-01 | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO and President | 321,898 | $0 | 465,934 (Direct) | View |
| 2021-12-27 Exercise | 2021-12-29 6:26 pm | N/A N/A | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO and President | 8,000 | $5.9 | 630,845 (Direct) | View |
| 2021-12-27 Exercise | 2021-12-29 6:26 pm | N/A 2027-07-05 | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO and President | 8,000 | $0 | 630,845 (Direct) | View |
| 2021-08-26 Option Award | 2021-08-30 4:15 pm | N/A N/A | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO and President | 78,219 | $0 | 144,036 (Direct) | View |
| 2021-02-01 Option Award | 2021-02-03 7:44 pm | N/A 2031-02-01 | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit See Remarks | 179,319 | $0 | 179,319 (Direct) | View |
| 2020-11-03 Exercise | 2020-11-05 7:00 pm | N/A N/A | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO and President | 9,507 | $5.9 | 1,062,805 (Direct) | View |
| 2020-11-03 Exercise | 2020-11-05 7:00 pm | N/A 2027-07-05 | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO and President | 9,507 | $0 | 1,062,805 (Direct) | View |
| 2020-10-23 Exercise | 2020-10-27 5:32 pm | N/A N/A | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO and President | 20 | $5.9 | 570,133 (Direct) | View |
| 2020-10-23 Exercise | 2020-10-27 5:32 pm | N/A 2027-07-05 | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO and President | 20 | $0 | 570,133 (Direct) | View |
| 2020-10-13 Exercise | 2020-10-15 8:24 pm | N/A N/A | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO and President | 14,472 | $5.9 | 1,074,594 (Direct) | View |
| 2020-10-13 Exercise | 2020-10-15 8:24 pm | N/A 2027-07-05 | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO and President | 14,472 | $0 | 1,074,594 (Direct) | View |
| 2020-09-08 Exercise | 2020-09-10 9:51 pm | N/A N/A | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO and President | 774 | $5.9 | 584,625 (Direct) | View |
| 2020-09-08 Exercise | 2020-09-10 9:51 pm | N/A 2027-07-05 | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO and President | 774 | $0 | 584,625 (Direct) | View |
| 2020-07-07 Exercise | 2020-07-09 6:48 pm | N/A N/A | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO and President | 3,047 | $5.9 | 1,107,274 (Direct) | View |
| 2020-07-07 Exercise | 2020-07-09 6:48 pm | N/A 2027-07-05 | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO and President | 3,047 | $0 | 1,107,274 (Direct) | View |
| 2020-06-22 Exercise | 2020-06-29 9:21 pm | N/A N/A | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO and President | 17,180 | $5.9 | 2,180,064 (Direct) | View |
| 2020-06-22 Exercise | 2020-06-29 9:21 pm | N/A 2027-07-05 | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO and President | 17,180 | $0 | 2,180,064 (Direct) | View |
| 2020-02-03 Option Award | 2020-02-03 5:32 pm | N/A 2030-02-03 | Spero Therapeutics Inc. | SPRO | Mahadevia Ankit CEO and President | 180,000 | $0 | 180,000 (Direct) | View |